HEMOCATH ​INTELLIGENT HEART FAILURE MONITORING PLATFORM

Transforming Heart Failure Treatment 
by Providing Actionable Clinical Data
for Optimal Medication Dosing and Treatment 
Reducing Hospitalization and Rehospitalization

​✓   Next generation of pulmonary artery catheters (4F)
✓   Substantially less invasive, more accurate and easier-to-use
✓   Solution to significant medical needs 
✓   Providing mobility to patients
✓   Connected to patients’ mobile phone & cloud
✓   Remote patient monitoring (SaaS, AI)
✓   Reducing hospital length of stay and rehospitalization
✓   Providing savings to hospitals

---

​HemoCath Pitch Video (5 minutes)

​PROBLEMS RESOLVED 

• Current methods to assess heart failure  are LATE and IMPRECISE
• ​Current medical devices to assess heart failure are TOO INVASIVE and RISKY​

​The two most important metrics for the treatment of heart failure are the pulmonary artery pressure (PA) and the central venous pressure (CVP). Unfortunately, these two metrics are not easily available today. So, cardiologists use several indirect methods that are LATE and IMPRECISE. Or, they use medical devices that are TOO INVASIVE and RISKY for most patients. Leading to suboptimal medication dosing, suboptimal treatment, longer hospital stay and rehospitalization.